Unjoni Ewropea - Malti - EMA (European Medicines Agency)

navidea biopharmaceuticals europe ltd. - tilmanocept - radjonuklidi imaging - jiġu identifikati t-tumuri, dijanjostiċi radjufarmaċewtiċi - dan il-prodott mediċinali huwa għal użu dijanjostiku biss. radjutikkettat lymphoseek huwa indikat għall-immaġini u waqt l-operazzjoni sejbien ta'sentinella nodi limfatiċi tqattir primarju tat-tumur fil-pazjenti adulti bil-kanċer tas-sider, melanoma, jew lokalizzata karċinoma b'ċelloli squamous tal-kavità orali. estern tal-immaġini u waqt l-operazzjoni ta'evalwazzjoni jista'jsir bl-użu tal-gamma-iskoperta tal-apparat.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - chicken - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunoloġiċi għall-għasafar - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - chicken - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

cycle pharmaceuticals (europe) ltd - nitisinone - tyrosinemias - oħra tal-passaġġ alimentari u tal-metaboliżmu-prodotti, - it-trattament tal-pazjenti adulti u pedjatriċi b'dijanjosi kkonfermata ta 'tirosinemia ereditarja ta' tip 1 (ht-1) flimkien ma 'restrizzjoni tad-dieta ta' tyrosine u phenylalanine.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

leo laboratories ltd. - ingenol mebutate - keratosis, actinic - l-antibijotiċi u l-kemoterapewtiċi għall-dermatoloġiċi-użu, kemoterapewtiċi oħra - picato huwa indikat għat-ġilda trattament ta mhux iperkeratotiċi, mhux ipertrofika ostruttiva keratosi aktinika fl-adulti.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

incline therapeutics europe ltd - fentanyl hydrochloride - uġigħ, wara l-operazzjoni - analġeżiċi - ionsys huwa indikat għall-immaniġġjar ta 'uġigħ akut post-operattiv moderat għal sever f'pazjenti adulti.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - aġenti antineoplastiċi - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - immunosoppressanti - jekk jogħġbok irreferi għad-dokument ta 'informazzjoni dwar il-prodott.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

mylan pharmaceuticals limited - zonisamide - epilessija - anti-epilettiċi, - monoterapija fit-trattament ta 'aċċessjonijiet parzjali bi jew mingħajr ġeneralizzazzjoni sekondarja, fil-adulti li jkunu għadhom kif ġew iddijanjostikati bl-epilessija;terapija aġġuntiva fit-trattament ta' aċċessjonijiet parzjali bi jew mingħajr ġeneralizzazzjoni sekondarja, fil-adulti, l-adoloxxenti u t-tfal ta ' 6 snin u aktar.